Search Results - "Hillege, H.L"

Refine Results
  1. 1

    Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients by van Deursen, V.M, Damman, K., MD, PhD, Hillege, H.L., MD, PhD, van Beek, A.P., MD, PhD, van Veldhuisen, D.J., MD, PhD, Voors, A.A., MD, PhD

    Published in Journal of cardiac failure (2010)
    “…Abstract Background We studied the relation between liver function abnormalities and hemodynamic profile in patients with heart failure (HF). Methods and…”
    Get full text
    Journal Article
  2. 2

    Risk Attitudes and Personality Traits Predict Perceptions of Benefits and Risks for Medicinal Products: A Field Study of European Medical Assessors by Beyer, Andrea R., MPH, Fasolo, Barbara, PhD, de Graeff, P.A., MD, Hillege, H.L., MD

    Published in Value in health (2015)
    “…Abstract Background: Risk attitudes and personality traits are known predictors of decision making among laypersons, but very little is known of their…”
    Get full text
    Journal Article
  3. 3

    Heart Failure Patients Monitored With Telemedicine: Patient Satisfaction, a Review of the Literature by Kraai, I.H., MSc, Luttik, M.L.A., MSc, PhD, de Jong, R.M., MD, PhD, Jaarsma, T., RN, PhD, Hillege, H.L., MD, PhD

    Published in Journal of cardiac failure (01-08-2011)
    “…Abstract Background Remote monitoring of the clinical status of heart failure patients has developed rapidly and is the subject of several trials. Patient…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Health-related quality of life and anemia in hospitalized patients with heart failure by Kraai, I.H, Luttik, M.L.A, Johansson, P, De Jong, R.M, Van Veldhuisen, D.J, Hillege, H.L, Jaarsma, T

    Published in International journal of cardiology (29-11-2012)
    “…Abstract Background Anemia is a serious and highly prevalent co-morbidity in chronic heart failure (HF) patients. Its influence on health-related quality of…”
    Get full text
    Journal Article
  6. 6

    BNP and NT-proBNP, Predictors of 1-Year Mortality in Nursing Home Residents by Barents, Maaike, MD, Hillege, Hans H.L., MD, PhD, MSc, van der Horst, Iwan C.C., MD, PhD, de Boer, Rudolph A., MD, PhD, Koster, J., MSc, Muskiet, Frits A.J., PhD, de Jongste, Mike J.L., MD, PhD

    “…Objectives To investigate 1-year mortality prediction of B type natriuretic peptide (BNP) and N terminal-proBNP (NT-proBNP) in institutionalized elderly with…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations by Cromme-Dijkhuis, A H, Henkens, C M, Bijleveld, C M, Hillege, H L, Bom, V J, van der Meer, J

    Published in The Lancet (British edition) (03-11-1990)
    “…Severe thromboembolism occurred in 3 of 37 patients who had undergone Fontan-type operations for correction of congenital heart defects several months to years…”
    Get more information
    Journal Article
  9. 9

    “Not getting worse” a qualitative study of patients perceptions of treatment goals in patients with heart failure by Kraai, I.H., Vermeulen, K.M., Hillege, H.L., Jaarsma, T.

    Published in Applied nursing research (01-02-2018)
    “…Knowledge of patient reported outcomes helps to provide personalized care on a patient level, optimize care on a population level, and identify the most…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Obesity and target organ damage: the kidney by Jong, P.E. de, Verhave, J.C, Pinto-Sietsma, S.J, Hillege, H.L

    Published in International Journal of Obesity (01-12-2002)
    “…Obesity is a risk marker for progressive renal function loss in patients with known renal disease. There is, however, increasing evidence that obesity may also…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial by Hillege, H.L., van Gilst, W.H., van Veldhuisen, D.J., Navis, G., Grobbee, D.E., de Graeff, P.A., de Zeeuw, D.

    Published in European heart journal (01-03-2003)
    “…Aims Information regarding the cardiorenal axis in patients after a myocardial infarction (MI) is limited. We examined the change in renal function after a…”
    Get full text
    Journal Article
  13. 13

    Gender‐specific correlations of plasminogen activator inhibitor‐1 and tissue plasminogen activator levels with cardiovascular disease‐related traits by ASSELBERGS, F. W., WILLIAMS, S. M., HEBERT, P. R., COFFEY, C. S., HILLEGE, H. L., NAVIS, G., VAUGHAN, D. E., VAN GILST, W. H., MOORE, J. H.

    Published in Journal of thrombosis and haemostasis (01-02-2007)
    “…Background: The purpose of this study was to examine the correlations between plasma levels of plasminogen activator inhibitor‐1 (PAI‐1) and tissue plasminogen…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Neurohormonal profile of patients with heart failure and diabetes by van der Horst, I. C. C., de Boer, R. A., Hillege, H. L., Boomsma, F., Voors, A. A., van Veldhuisen, D. J.

    Published in Netherlands heart journal (01-04-2010)
    “…Background. Neurohormonal activation is generally recognised to play an important role in the pathophysiology, prognosis and treatment of chronic heart failure…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20